Role of TRPV1 channels on glycogen synthase kinase-3β and oxidative stress in ouabain-induced bipolar disease

References

• Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry. 2010;71(12):1689–1695.
   PubMed Web of Science ®Google Scholar
• Torpy JM. Bipolar disorder. JAMA. 2009;301(5):564.
   PubMed Web of Science ®Google Scholar
• Chiu C-T, Wang Z, Hunsberger JG, et al. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013;65(1):105–142.
   PubMed Web of Science ®Google Scholar
• Connolly KR, Thase ME. The clinical management of bipolar disorder. Prim Care Companion Cns Disord. 2011;13(4):PCC.10r01097.
   PubMedGoogle Scholar
• Herman L, Hougland T, El-Mallakh RS. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev. 2007;31(6):874–881.
   PubMed Web of Science ®Google Scholar
• Valvassori SS, Dal-Pont GC, Resende WR, et al. Validation of the animal model of bipolar disorder induced by Ouabain: face, construct and predictive perspectives. Transl Psychiatry. 2019;9(1):158.
   PubMedGoogle Scholar
• de Sousa RT, Zarate CA, Zanetti MV, et al. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psychiatr Res. 2014;50:36–41.
   PubMed Web of Science ®Google Scholar
• Jornada LK, Valvassori SS, Steckert AV, et al. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. J Psychiatr Res. 2011;45(2):162–168.
   PubMed Web of Science ®Google Scholar
• Riegel RE, Valvassori SS, Elias G, et al. Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem Int. 2009;55(7):491–495.
   PubMed Web of Science ®Google Scholar
• Nazıroglu M, Demirdas A. Psychiatric disorders and TRP channels: focus on psychotropic drugs. CN. 2015;13(2):248–257.
   Google Scholar
• Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 1990;9(8):2431–2438.
   PubMed Web of Science ®Google Scholar
• Jope RS, Johnson GVW. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29(2):95–102.
   PubMed Web of Science ®Google Scholar
• Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A. 1996;93(16):8455–8459.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65(4):391–426.
   PubMed Web of Science ®Google Scholar
• Prickaerts J, Moechars D, Cryns K, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci. 2006;26(35):9022–9029.
   PubMed Web of Science ®Google Scholar
• Forde JE, Dale TC. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci. 2007;64(15):1930–1944.
   PubMed Web of Science ®Google Scholar
• Hong C, Jeong B, Park HJ, et al. TRP channels as emerging therapeutic targets for neurodegenerative diseases. Front Physiol. 2020;11:238.
   PubMed Web of Science ®Google Scholar
• Santoni G, Maggi F, Amantini C, et al. Pathophysiological role of transient receptor potential mucolipin channel 1 in calcium-mediated stress-induced neurodegenerative diseases. Front Physiol. 2020; 11:251.
   PubMed Web of Science ®Google Scholar
• Wanner SP, Garami A, Romanovsky AA. Hyperactive when young, hypoactive and overweight when aged: connecting the dots in the story about locomotor activity, body mass, and aging in Trpv1 knockout mice. Aging. 2011;3(4):450–454.
   PubMedGoogle Scholar
• Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US); 2011.
   Google Scholar
• Percie Du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. BMC Vet Res. 2020;16(1):242.
   PubMed Web of Science ®Google Scholar
• Valvassori SS, Dal-Pont GC, Resende WR, et al. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain. Neuropharmacology. 2017;117:447–459.
   PubMed Web of Science ®Google Scholar
• Kim SH, Yu H-S, Park HG, et al. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity. Prog Neuropsychopharmacol Biol Psychiatr. 2008;32(7):1637–1642.
   PubMed Web of Science ®Google Scholar
• Saito A, Yamamoto M. Acute oral toxicity of capsaicin in mice and rats. J Toxicol Sci. 1996;21(3):195–200.
   PubMedGoogle Scholar
• Baskaran P, Markert L, Bennis J, et al. Assessment of pharmacology, safety, and metabolic activity of capsaicin feeding in mice. Sci Rep. 2019;9(1):8588.
   PubMedGoogle Scholar
• Motte J, Ambrosius B, Grüter T, et al. Capsaicin-enriched diet ameliorates autoimmune neuritis in rats. J Neuroinflammation. 2018;15(1):122.
   PubMedGoogle Scholar
• Sakakibara M, Anderson EM, Jenkins AC, et al. The effects of a co-application of menthol and capsaicin on nociceptive behaviors of the rat on the operant orofacial pain assessment device. PLOS One. 2014;9(2):e89137.
   Web of Science ®Google Scholar
• Walker KM, Urban L, Medhurst SJ, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther. 2003;304(1):56–62.
   PubMed Web of Science ®Google Scholar
• Akabori H, Yamamoto H, Tsuchihashi H, et al. Transient receptor potential vanilloid 1 antagonist, capsazepine, improves survival in a rat hemorrhagic shock model. Ann Surg. 2007;245(6):964–970.
   PubMed Web of Science ®Google Scholar
• Nguyen TL, Nam YS, Lee SY, et al. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice. Br J Anaesth. 2010;105(5):668–674.
   PubMed Web of Science ®Google Scholar
• Valvassori SS, Resende WR, Lopes-Borges J, et al. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway. J Psychiatr Res. 2015;65:63–70.
   PubMed Web of Science ®Google Scholar
• Kirshenbaum GS, Clapcote SJ, Duffy S, et al. Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase α3 sodium pump. Proc Natl Acad Sci U S A. 2011;108(44):18144–18149.
   PubMed Web of Science ®Google Scholar
• Serchov T, van Calker D, Biber K. Sucrose preference test to measure anhedonic behaviour in mice. Bio-Protocol. 2016;6(19):1958.
   Google Scholar
• He F. BCA (bicinchoninic acid) protein assay. Bio-Protocol. 2011;1(5):44.
   Google Scholar
• Dieckmann-Schuppert A, Schnittler H-J. A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces. Cell Tissue Res. 1997;288(1):119–126.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004;37(4):277–285.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111.
   PubMed Web of Science ®Google Scholar
• Lichtstein D, Ilani A, Rosen H, et al. Na+, K+-ATPase signaling and bipolar disorder. IJMS. 2018;19(8):2314.
   Google Scholar
• Gulyani S, Mallick BN. Possible mechanism of rapid eye movement sleep deprivation induced increase in NaK ATPase activity. Neuroscience. 1995;64(1):255–260.
   PubMed Web of Science ®Google Scholar
• Baskaran P, Krishnan V, Fettel K, et al. TRPV1 activation counters diet-induced obesity through sirtuin-1 activation and PRDM-16 deacetylation in brown adipose tissue. Int J Obes. 2017;41(5):739–749.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li L, Hua Y, et al. Cardiac-specific knockout of ET(A) receptor mitigates low ambient temperature-induced cardiac hypertrophy and contractile dysfunction . J Mol Cell Biol. 2012;4(2):97–107.
   PubMed Web of Science ®Google Scholar
• Grueter BA, Brasnjo G, Malenka RC. Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens . Nat Neurosci. 2010;13(12):1519–1525.
   PubMed Web of Science ®Google Scholar
• Madasu MK, Roche M, Finn DP. Supraspinal transient receptor potential subfamily V member 1 (TRPV1) in pain and psychiatric disorders. Mod Trends Pharmacopsychiatry. 2015;30:80–93.
   PubMedGoogle Scholar
• Hudson ASR, Kunstetter AC, Damasceno WC, et al. Involvement of the TRPV1 channel in the modulation of spontaneous locomotor activity, physical performance and physical exercise-induced physiological responses. Braz J Med Biol Res. 2016;49(6):e5183.
   PubMed Web of Science ®Google Scholar
• Aguiar DC, Terzian ALB, Guimarães FS, et al. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology. 2009;205(2):217–225.
   PubMed Web of Science ®Google Scholar
• Marrone MC, Morabito A, Giustizieri M, et al. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017;8(1):15292.
   PubMedGoogle Scholar
• Storozhuk MV, Moroz OF, Zholos AV. Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and some visceral systems. Biomed Res Int. 2019;2019:5806321.
   PubMed Web of Science ®Google Scholar
• You I-J, Jung Y-H, Kim M-J, et al. Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HT₁A, GABA(A), and NMDA receptors. Neuropharmacology. 2012;62(2):1034–1043.
   PubMed Web of Science ®Google Scholar
• Chuang H, Lin S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc Natl Acad Sci U S A. 2009;106(47):20097–20102.
   PubMed Web of Science ®Google Scholar
• Czaja K, Burns GA, Ritter RC. Capsaicin-induced neuronal death and proliferation of the primary sensory neurons located in the nodose ganglia of adult rats. Neuroscience. 2008;154(2):621–630.
   PubMed Web of Science ®Google Scholar
• Hamed M, Kalita D, Bartolo ME, et al. Capsaicinoids, polyphenols and antioxidant activities of Capsicum annuum: comparative study of the effect of ripening stage and cooking methods. Antioxidants. 2019;8(9):364.
   Web of Science ®Google Scholar
• Zhai K, Liskova A, Kubatka P, et al. Calcium entry through TRPV1: a potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells. IJMS. 2020;21(11):4177.
   Google Scholar
• Luca A, Calandra C, Luca M. Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy. Oxid Med Cell Longev. 2016;2016:3030547–3030512.
   PubMed Web of Science ®Google Scholar
• Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114–131.
   PubMed Web of Science ®Google Scholar
• Kanninen K, White AR, Koistinaho J, et al. Targeting glycogen synthase kinase-3βfor therapeutic benefit against oxidative stress in Alzheimer’s disease: involvement of the Nrf2-ARE pathway. Int J Alzheimers Dis. 2011;2011:985085–985089.
   PubMedGoogle Scholar
• Mahmmoud YA, Shattock M, Cornelius F, et al. Inhibition of K + transport through Na+, K+-ATPase by capsazepine: role of membrane span 10 of the α-subunit in the modulation of ion gating. PLOS One. 2014;9(5):e96909.
   PubMed Web of Science ®Google Scholar
• Mahmmoud YA. Capsazepine, a synthetic vanilloid that converts the Na,K-ATPase to Na-ATPase. Proc Natl Acad Sci U S A. 2008;105(5):1757–1761.
   PubMed Web of Science ®Google Scholar